期刊文献+

PET-CT最大标准摄取值定量评估胃癌组织中HER2的表达情况 被引量:4

Correlation between PET-CT maximum standardized uptake value and HER2 expression in gastric carcinoma
下载PDF
导出
摘要 目的:探讨人表皮生长因子受体2(human epidermal growth factor receptor 2,HER2)表达程度与正电子发射断层扫描(positron emission tomography,PET)-CT标化摄取值(standardized uptake value,SUV)max的关系,从而定量评价胃癌组织中HER2表达情况,进而间接评价胃癌的生物学特性.方法:回顾性分析57例郑州大学第一附属医院胃腺癌患者的PET-CT扫描资料,测量最大标准摄取值.应用免疫组织化学方法检测胃癌中HER2的表达,用统计学方法分析SUVmax与HER2的相关性.结果:所有患者HER2阳性者28例,HER2表达阳性率为49.12%,按照统计学方法分析得出HER2阳性组SUVmax高于阴性组,且差异具有统计学意义(8.9357±4.21375 vs 4.6448±3.18597,P=0.000).SUVmax与HER2呈中度正相关,相关系数为0.581.以SUVmax为参考值绘制受试者工作特征曲线,曲线下面积为0.83,根据不同SUVmax值所对应特异度、灵敏度及约登指数可得出,当SUVmax值为5.800时所对应的约登指数越大,灵敏度为82.1%,特异度为79.8%.结论:胃癌组织中SUVmax与胃癌病灶中的H E R2的表达具有一定的相关性,能较好的评估胃癌的生物学特性. AIM: To investigate the relationship between the maximum standardized uptake value(SUVmax) and human epidermal growth factor receptor 2(HER2) expression in gastric carcinoma. METHODS: Sixty-one patients who underwent PET-CT at our hospital and had pathologically proven gastric adenocarcinoma were included, and SUVmax was measured. HER2 expression was detected by immunohistochemistry. The correlation between SUVmax and HER2 expression was analyzed statistically.RESULTS: Of all the patients, 28 were positive for HER2, with a positive rate of 49.12%. The SUVmax for the HER2 positive group was 4.6448 ± 3.18597, which was significantly higher than that for the HER2 negative group(P = 0.000). There was a moderate positive correlation between SUVmax and HER2, and the correlation coefficient was 0.581. According to the ROC analysis, the area under the curve of SUVmax was 0.83. Taking 5.800 as the threshold of SUVmax, the corresponding sensitivity and specificity were 82.1% and 79.8%, respectively. CONCLUSION : There is a moderate correlation between SUVmax and HER2 in gastric adenocarcinoma, and SUVmax can help assess the biological characteristics of gastric cancer.
出处 《世界华人消化杂志》 CAS 2016年第15期2312-2318,共7页 World Chinese Journal of Digestology
基金 国家自然科学基金项目 No.81271573~~
关键词 计算机断层扫描 正电子发射型计算机断层显像 18氟-氟代脱氧葡萄糖 人表皮生长因子受体2 胃腺癌 Computed tomography Posi tron emission tomography Fluorine-18 fluorodeoxyglucose Human epidermal growth factor receptor 2 Gastric cancer
  • 相关文献

参考文献5

二级参考文献35

  • 1Lucas Faria Abraho-Machado,Alexandre Andrade dos Anjos Jácome,Durval Renato Wohnrath,José Sebastio dos Santos,Estela Cristina Carneseca,José Humberto Tavares Guerreiro Fregnani,Cristovam Scapulatempo-Neto.HER2 in gastric cancer: Comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays[J].World Journal of Gastroenterology,2013,19(38):6438-6446. 被引量:13
  • 2陈斌,罗荣城,崔斐,钱新宇.胃癌HER-2/neu基因表达与预后的相关性[J].南方医科大学学报,2006,26(3):344-347. 被引量:44
  • 3朱仁娟,刘松涛,王莉.胃癌PET-CT显像的临床应用[J].医学影像学杂志,2006,16(6):586-588. 被引量:8
  • 4郭华,高剑波,杨学华,周志刚,陈学军,岳松伟.螺旋CT三期增强扫描对进展期胃癌的诊断价值[J].实用放射学杂志,2006,22(9):1059-1062. 被引量:15
  • 5董孟杰,林祥通,赵军,管一晖,左传涛,陈香,戴嘉中,姜保东.17例恶性肿瘤^(18)氟脱氧葡萄糖PET显像假阴性的分析[J].中华肿瘤杂志,2006,28(9):713-717. 被引量:13
  • 6郭华,高剑波,张永高,张智栩,陈奎生,张云汉,张谢夫.胃癌螺旋CT与病理、nm23-H_1蛋白表达的相关性研究[J].临床放射学杂志,2006,25(10):923-927. 被引量:3
  • 7Giuseppe Perrone,Michelina Amato,Marcella Callea,Carla Rabitti,Daniela Righi,Pierfilippo Crucitti,Roberto Coppola,Andrea Onetti Muda.HER2 amplification status in gastric and gastro‐oesophageal junction cancer in routine clinical practice: which sample should be used?[J]. Histopathology . 2012 (1)
  • 8Jiyuan Yang,Hesheng Luo,Yan Li,Junchuan Li,Zhiqiang Cai,Xiaoyan Su,Danqing Dai,Wei Du,Tingxuan Chen,Ming Chen.Intratumoral Heterogeneity Determines Discordant Results of Diagnostic Tests for Human Epidermal Growth Factor Receptor (HER) 2 in Gastric Cancer Specimens[J]. Cell Biochemistry and Biophysics . 2012 (1)
  • 9Heike Grabsch,Shivan Sivakumar,Sally Gray,Helmut E. Gabbert,Wolfram Müller.HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value – conclusions from 924 cases of two independent series[J]. Cellular Oncology . 2010 (1-2)
  • 10Yung-Jue Bang,Eric Van Cutsem,Andrea Feyereislova,Hyun C Chung,Lin Shen,Akira Sawaki,Florian Lordick,Atsushi Ohtsu,Yasushi Omuro,Taroh Satoh,Giuseppe Aprile,Evgeny Kulikov,Julie Hill,Michaela Lehle,Josef Rüschoff,Yoon-Koo Kang.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial[J]. The Lancet . 2010 (9742)

共引文献31

同被引文献59

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部